{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "841105", "DateCompleted": {"Year": "1977", "Month": "04", "Day": "15"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "23"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0090-6980", "JournalIssue": {"Volume": "13", "Issue": "1", "PubDate": {"Year": "1977", "Month": "Jan"}}, "Title": "Prostaglandins", "ISOAbbreviation": "Prostaglandins"}, "ArticleTitle": "Intramuscular prostaglandin (15S)-15-methyl PGF2alpha (THAM) in midtrimester abortion.", "Pagination": {"StartPage": "183", "EndPage": "191", "MedlinePgn": "183-91"}, "Abstract": {"AbstractText": ["Elective termination of second trimester pregnancies in 63 patients by means of intramuscular prostaglandin (15S)-15-Methyl PGF2alpha (THAM) is reported. In 44 of 61 cases with a successful outcome the duration of pregnancy calculated from a last normal menstrual period was between 13 and 17 weeks. An overall success rate of 96.8 per cent was achieved; and this agent and method warrant further clinical evaluation."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Henriques", "ForeName": "E S", "Initials": "ES"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Etkin", "ForeName": "R H", "Initials": "RH"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Lee", "ForeName": "J D", "Initials": "JD"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Swartz", "ForeName": "D P", "Initials": "DP"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Prostaglandins", "NlmUniqueID": "0320271", "ISSNLinking": "0090-6980"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Prostaglandins F"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Abortion, Induced"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Diarrhea"}, {"QualifierName": [], "DescriptorName": "Dilatation and Curettage"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Injections, Intramuscular"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Pregnancy"}, {"QualifierName": [], "DescriptorName": "Pregnancy Trimester, Second"}, {"QualifierName": [], "DescriptorName": "Premedication"}, {"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Prostaglandins F"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Vomiting"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1977", "Month": "1", "Day": "1"}, {"Year": "1977", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1977", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["841105", "10.1016/0090-6980(77)90055-7", "0090-6980(77)90055-7"]}}]}